Skip to main content

Immune-Related Adverse Events Secondary to Checkpoint-Inhibitor Therapy

Tracking # 20-670292

Free

5 (1 ratings)
Learn more
Educator ASCP
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The rapid rate of breakthroughs in immuno-oncology has outpaced continuing education in medicine, leaving pathologists and laboratory teams without optimal awareness about the core science of pan-tumor immuno-oncology checkpoints, biomarkers, pathways, and therapeutics. A growing body of research has documented the impact of advances in immunotherapy treatments on pathology diagnostics, but the laboratory team currently possesses suboptimal skills in recognizing side effects, especially immune-related adverse events (irAEs), induced by these novel therapies and checkpoint inhibitors including those that target PD-1/ PD-L1. This case based online course will discuss common immune-related adverse events (irAEs) in patients undergoing immunotherapy, addressing the following topics: irAEs onset and frequency; reporting of irAEs in pathology reports; coverage of hepatic, pancreatic, cutaneous, and cardiac irAEs and their management and outcomes; and detailed discussion of patterns of injury in the gut for gastrointestinal irAEs. Learning Objectives: 1) Identify common immune-related adverse events (irAEs) in patients undergoing checkpoint-inhibitor therapy, including their onset and frequency, recognition of tissue based patterns of injury which a surgical pathologist may see in routine practice, that pathologists need to know and include in reporting. The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. These activities also meet MOC Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements. ASCP designates these live activities for a maximum of 1.0 CMLE credit. These activities meet CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a .m. to 6 p.m. Eastern Time Method of Participation To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line. Funded by an independent educational grant from Bristol-Myers Squibb.

Subject areas

This course counts toward the state boards and subject areas below.

Louisiana State Board of Medical Examiners - Clinical Lab Personnel

Cytotechnologist

1h Continuing Education for Clinical Laboratory Personnel

Generalist

1h Continuing Education for Clinical Laboratory Personnel

Laboratory Assistant

1h Continuing Education for Clinical Laboratory Personnel

Phlebotomist

1h Continuing Education for Clinical Laboratory Personnel

Specialist

1h Continuing Education for Clinical Laboratory Personnel

Technician

1h Continuing Education for Clinical Laboratory Personnel

Tennessee Medical Laboratory Board

Laboratory Personnel

1h Continuing education pertaining to laboratory technology or laboratory management

Learner Feedback